Apollo Hospitals Enterprise Ltd

Large Cap

Healthcare Sector

reflects a positive outlook for the share price

reflects a neutral outlook for the share price

reflects a negative outlook for the share price

The analysts information is for reference only and does not\n  represents an investment recommendation.

Analyst recommendation reflect the views of analysts who follow and write research reports.

Company Information is an introduction to the company’s business that details what it sell, how it was founded, what their mission is, how they manufacture or source their products, and why they serve customers.

Apollo Diagnostics has launched a fully automated Digi-Smart Central Reference Laboratory in Chennai, enhancing diagnostic efficiency and accuracy. The lab aims to process up to 100,000 samples daily and introduces advanced genomic testing services, addressing global health challenges.

Apollo Diagnostics Launches Advanced Digi-Smart Lab - 30 Apr, 2025

Apollo Hospitals Enterprise Limited (AHEL) owns a 25% stake in Indraprastha Medical Corporation (IMCL), highlighting its strong operational and financial connections within the healthcare sector.

Apollo Hospitals Holds Significant Stake in IMCL - 28 Apr, 2025

Apollo Hospitals Enterprise Ltd experienced a significant increase in trading volume, reaching 4.85 lakh shares, a 171.71-fold rise compared to the two-week average. However, the stock price fell by 2.76% to Rs. 6,963.35.

Apollo Hospitals Sees Surge in Trading Volume - 25 Apr, 2025

Apollo Hospitals is planning significant expansions in North India while facing stock declines and scrutiny over a past incident involving a 'fake doctor'. The company aims to add 3,500 beds to meet rising healthcare demand.

Apollo Hospitals Faces Challenges Amid Expansion Plans - 11 Apr, 2025

Apollo Hospitals Enterprise Ltd will invest ₹6,000 crore over five years to add 3,500 new beds, focusing on high-burden specialties like oncology and cardiology. The first phase targets 1,737 beds in key urban centers by FY26, while the second phase will add 1,775 beds in additional cities.

Apollo Hospitals Plans Major Expansion with ₹6,000 Crore Investment - 09 Apr, 2025

Apollo Hospitals' latest report indicates a surge in undiagnosed chronic diseases among Indians, particularly affecting younger populations. It calls for immediate preventive healthcare measures and highlights alarming trends in lifestyle diseases, emphasizing the need for proactive health strategies.

Apollo Hospitals Highlights Rising Health Crisis in India - 07 Apr, 2025

Apollo Hospitals is demonstrating strong momentum, trading above crucial moving averages. Analysts suggest initiating long positions with a target of ₹6,900 and a stop loss at ₹6,500.

Apollo Hospitals Shows Strong Momentum and Potential Upside - 04 Apr, 2025

Kotak Securities highlights Apollo Hospitals' seven consecutive quarters of margin improvement and sets a price target of ₹8,180, indicating a potential upside of 24%. However, concerns remain regarding its 24/7 business and bed expansion strategy compared to peers.

Kotak Securities Optimistic on Apollo Hospitals - 02 Apr, 2025

Price to Earnings Ratio or Price to Earnings Multiple is the ratio of the share price of a stock to its earnings per share (EPS). It provides an indication of whether a stock at its current market price is expensive or cheap.

The price/earnings-to-growth ratio, or the PEG ratio, is a metric that helps investors value a stock by taking into account a company's market price, its earnings, and its future growth prospects.

Enterprise value (EV) is the total value of a company, defined in terms of its financing. It includes both the current share price (market capitalization) and the cost to pay off debt (net debt, or debt minus cash).

Alpha measures the amount that the investment has returned in comparison to the market index or other broad benchmark that it is compared against.

Beta measures a stock's volatility, the degree to which its price fluctuates in relation to the overall stock market. In other words, it gives a sense of the stock's risk compared to that of the greater market.

Dividend yield measures the quantum of earnings by way of total dividends that investors make by investing in that company.

The debt-to-total-assets ratio shows how much of a business is owned by creditors (people it has borrowed money from) compared with how much of the company's assets are owned by shareholders.

Operating cash flow (OCF) is a measure of the amount of cash generated by a company's normal business operations. Operating cash flow indicates whether a company can generate sufficient positive cash flow to maintain and grow its operations.

This widget shows the information about the stock's peers in consideration along with the different data for those peers so that the user can compare the stock with the other similar stock and invest accordingly.

Promoter holding is the amount of share of the company that is owned by the promoters. The promoters are the company's founders, who hold a majority stake in the company's capital.

A foreign institutional investor (FII) is an investor or investment fund investing in a country outside of the one in which it is registered or headquartered.

A mutual fund is a pool of money managed by a professional Fund Manager. It is a trust that collects money from a number of investors who share a common investment objective and invests the same in equities, bonds, money market instruments, and other securities.

Retail investors execute their trades through traditional or online brokerage firms or other types of investment accounts. Retail investors purchase securities for their own personal accounts and often trade in dramatically smaller amounts as compared to institutional investors.

This widget shows the bifurcation of stocks based on the percentage of stake with the different types of shareholders.

This widget will help value the stock based on the Price to Earning ratio of the stock and compare the valuation with the industry value and other similar stocks. It even shows the timeline of the valuation of the stock and its highest and lowest valuation over time.
A Time Series data is provided which compares the historical stock PE with Industry PE over the period of 5 years.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

Promoters have increased holdings from 29.33% to 29.34% in Mar 2025 quarter

This section gives you an insight into how the Promoter Holding has changed for the stock over the last few quarters.

Promoter Holding Up

Retail Investor have increased holdings from 5.19% to 5.41% in Mar 2025 quarter

This section gives you an insight into how the Retail Investors Holding has changed for the stock over last few quarters.

Retail Holding Up

Mutual Funds have increased holdings from 12.77% to 15.42% in Mar 2025 quarter

This section gives you an insight into how the Mutual Funds Holding has changed for the stock over last few quarters.

MF Holding Up

In the last 1 month, APOLLOHOSP stock has moved up by 4.2%

This section gives you an insight into the price movement of the stock for the last few quarters.

Price Rise

In the last 3 years, Max Healthcare Institute Ltd has given 191.7% return, outperforming this stock by 118.4%

This section gives you an insight into how the peers have performed as compared to this company in the last 3 years.

Against Peers

In the last 1 year, Fortis Healthcare Ltd has given 50.2% return, outperforming this stock by 34.4%

This section gives you an insight into how the peers have performed as compared to this company in the last 1 year.

Netprofit is down for the last 2 quarters, 378.8 Cr → 372.3 Cr (in ₹), with an average decrease of 1.7% per quarter

This section gives you an insight into how the profit for the company has been for the last few quarters.

Profit Down

Foreign Institutions have decreased holdings from 45.27% to 42.74% in Mar 2025 quarter

This section gives you an insight into how the FII Holding has changed for the stock over last few quarters.

FII Holding Down

Revenue is down for the last 2 quarters, 5.63K Cr → 5.59K Cr (in ₹), with an average decrease of 0.7% per quarter

This section gives you an insight into how the revenue of the company has moved for the last few quarters.

Revenue Fall

Nifty Services Sector

BSE Healthcare

BSE 100

Nifty100 Low Volatility 30

S&P BSE 250 LargeMidCap

S&P BSE 100 LargeCap TMC

S&P BSE Low Volatility

NIFTY 100

Nifty India Consumption

Nifty 200

S&P BSE 100 ESG

BSE 200

S&P BSE Largecap

Nifty Healthcare

Nifty100 Eq Weig

Nifty LargeMidcap 250

S&P BSE Dividend Stability

Nifty 500

S&P BSE SENSEX 50

NIFTY 50

Nifty Infra

BSE 500

HDFC Flexi Cap Fund -Direct Plan - Growth Option

Mirae Asset Large Cap Fund Direct Plan Growth

Invesco India Contra Fund Direct Plan Growth

Mirae Asset Large & Midcap Fund Direct Plan Growth

Nippon India Pharma Fund - Direct Plan - Growth Plan

Apollo Hospitals Enterprise Ltd’s net profit jumped 51.77% since last year same period to ₹372.30Cr in the Q3 2024-2025. On a quarterly growth basis, Apollo Hospitals Enterprise Ltd has generated -1.72% fall in its net profits since last 3-months.

Name	Value	Action
MACD level (12,26)	-1.67	Bearish
CCI (20)	575.53	Bearish
RSI (14)	24.62	Bullish
Momentum (10)	-24	Bearish
ADI (14)	22.58	Neutral
Ultimate Oscillator (7,14,28)	11.9	Bearish

Name	Value	Action
SMA (20)	6950.92	Bearish
EMA (20)	6950.18	Bearish
VWMA (20)	6950.33	Bearish
SMA (50)	6949.77	Bearish
EMA (50)	6949.56	Bearish
SMA (200)	6940.57	Bearish
EMA (200)	6951.2	Bearish
KAMA (200)	6946.37	Bearish
DEMA (200)	6939.23	Bearish

Apollo Hospitals Enterprise Ltd (APOLLOHOSP)

Summary

Overall

Oscillators

Moving Averages